Loading clinical trials...
Loading clinical trials...
Comparison Of The Efficacy Of Combination Of TAM Formula Versus Kligman Formula For Melasma At Tertiary Care Hospital,Karachi.
Conditions
Interventions
TAM formula (hydroquinone 2%, tretinoin 0.05% and 5% vitamin C)
Kligman formula (hydroquinone 4%, fluocinolone acetonide 0.01% and tretinoin 0.05%)
Locations
1
Pakistan
JPMC
Karachi, Sindh, Pakistan
Start Date
August 1, 2022
Primary Completion Date
December 1, 2022
Completion Date
August 30, 2023
Last Updated
August 28, 2023
NCT06516419
NCT07296549
NCT06644157
NCT07345507
NCT06957834
NCT05326997
Lead Sponsor
Jinnah Postgraduate Medical Centre
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions